SEC Form 4 · accession 0001162194-15-000063
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Maxwell Smith
Officer — EVP, LEGAL AFFAIRS & GC
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2015 | M | 2,327 | $4.0828 | A | 3,249 | D | |
| Common Stock | Mar 16, 2015 | M | 673 | $4.4461 | A | 3,922 | D | |
| Common Stock | Mar 16, 2015 | S | 3,000 | $40.87 | D | 922 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $4.0828 | Mar 16, 2015 | M | 2,327 | D | — | Nov 17, 2019 | Common Stock | 2,327 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $4.4461 | Mar 16, 2015 | M | 673 | D | — | Apr 23, 2018 | Common Stock | 673 | 4,503 | D |
Explanation of responses
- F1The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2014.
- F2The shares subject to the Option fully vested on April 1, 2013.
- F3The shares subject to the Option fully vested on May 1, 2008.